These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 10559578)

  • 1. Reactivity at edges of corticosteroid patch tests may be an indicator of a strong positive test response.
    Bjarnason B; Flosadóttir E; Fischer T
    Dermatology; 1999; 199(2):130-4. PubMed ID: 10559578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of budesonide patch tests.
    Bjarnason B; Flosadóttir E; Fischer T
    Contact Dermatitis; 1999 Oct; 41(4):211-7. PubMed ID: 10515100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patch testing with budesonide in serial dilutions: the significance of dose, occlusion time and reading time.
    Isaksson M; Bruze M; Goossens A; Lepoittevin JP
    Contact Dermatitis; 1999 Jan; 40(1):24-31. PubMed ID: 9928801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patch testing with budesonide in serial dilutions. A multicentre study of the EECDRG.
    Isaksson M; Andersen KE; Brandão FM; Bruynzeel DP; Bruze M; Diepgen T; Ducomb G; Frosch PJ; Goossens A; Lahti A; Menné T; Seidenari S; Tosti A; Wahlberg J; Wilkinson JD
    Contact Dermatitis; 2000 Jun; 42(6):352-4. PubMed ID: 10871102
    [No Abstract]   [Full Text] [Related]  

  • 5. Reactions to other corticosteroids in patients with positive patch test reactions to budesonide.
    Wilkinson M; Hollis S; Beck M
    J Am Acad Dermatol; 1995 Dec; 33(6):963-8. PubMed ID: 7490366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patch testing with neomycin sulfate.
    Bjarnason B; Flosadóttir E
    Contact Dermatitis; 2000 Nov; 43(5):295-302. PubMed ID: 11016671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dark test-substance pigmentation on skin perfusion assessments and effect of test technique on balsam of Peru patch-test results.
    Bjarnason B; Flosadóttir E; Fischer T
    Contact Dermatitis; 2000 Jun; 42(6):318-25. PubMed ID: 10871094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cross-reactivity between budesonide and desonide.
    Foti C; Cassano N; Vena GA
    Contact Dermatitis; 2002 Aug; 47(2):109-10. PubMed ID: 12423417
    [No Abstract]   [Full Text] [Related]  

  • 9. Corticosteroids.
    Isaksson M
    Dermatol Ther; 2004; 17(4):314-20. PubMed ID: 15327476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contact sensitivity to budesonide in a child.
    Auricchio L; Nino M; Suppa F
    Contact Dermatitis; 2000 Jun; 42(6):359. PubMed ID: 10871107
    [No Abstract]   [Full Text] [Related]  

  • 11. Objective non-invasive assessment of patch tests with the laser Doppler perfusion scanning technique.
    Bjarnason B; Flosadóttir E; Fischer T
    Contact Dermatitis; 1999 May; 40(5):251-60. PubMed ID: 10344480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of test techniques of perfusion of neomycin sulfate patch tests. A comparative study with visual assessments.
    Bjarnason B; Flosadóttir E
    Contact Dermatitis; 2000 Nov; 43(5):283-94. PubMed ID: 11016670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patch testing with budesonide.
    Wilkinson SM; Beck MH
    Contact Dermatitis; 1998 Jul; 39(1):52-3. PubMed ID: 9686997
    [No Abstract]   [Full Text] [Related]  

  • 14. Patch testing with serial dilutions of budesonide, its R and S diastereomers, and potentially cross-reacting substances.
    Isaksson M; Bruze M; Lepoittevin JP; Goossens A
    Am J Contact Dermat; 2001 Sep; 12(3):170-6. PubMed ID: 11526524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patch testing for corticosteroid allergy using high and low concentrations.
    Wilkinson SM; Beck MH
    Contact Dermatitis; 2000 Jun; 42(6):350-1. PubMed ID: 10871100
    [No Abstract]   [Full Text] [Related]  

  • 16. Patch testing with low concentrations of budesonide detects contact allergy.
    Isaksson M; Bruze M; Matura M; Goossens A
    Contact Dermatitis; 1997 Nov; 37(5):241-2. PubMed ID: 9412759
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of systemic allergic dermatitis caused by inhaled budesonide: cross-reactivity in patch tests with the novel inhaled corticosteroid ciclesonide.
    Salava A; Alanko K; Hyry H
    Contact Dermatitis; 2012 Oct; 67(4):244-6. PubMed ID: 22957490
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of balsam of Peru patch tests.
    Bjarnason B; Flosadóttir E; Fischer T
    Contact Dermatitis; 2000 Jun; 42(6):326-9. PubMed ID: 10871095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low yield for extended reading of patch tests with topical corticosteroids.
    Davis MD; Richardson DM; Farmer SA
    Dermatitis; 2005 Sep; 16(3):124-6. PubMed ID: 16242083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticosteroid hypersensitivity studies in a skin allergy clinic.
    Berbegal L; DeLeon FJ; Silvestre JF
    Actas Dermosifiliogr; 2015 Dec; 106(10):816-22. PubMed ID: 26344737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.